Natrijev Oksibat Kalceks (Sodium Oxybate)

Sodium oxybate acts on the central nervous system to modify sleep architecture in patients with narcolepsy.

• Narcolepsy with cataplexy: reduces the frequency and severity of cataplexy attacks and improves overall sleep quality.
• Excessive daytime sleepiness (narcolepsy): enhances wakefulness during the day by consolidating nocturnal sleep.
• Disrupted nighttime sleep (narcolepsy): decreases nocturnal awakenings and restores a more normal sleep pattern.

• Sodium oxybate binds to and activates GABA_B receptors in the brain, enhancing inhibitory neurotransmission. This action modulates the sleep‑wake cycle, stabilizes sleep architecture, and reduces the occurrence of cataplexy by dampening neuronal excitability during REM sleep transitions.

Sodium oxybate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.
• Vomiting: occasional emesis.
• Insomnia: difficulty maintaining sleep.
• Weight loss: reduced appetite.

Serious or Rare Side Effects

• Respiratory depression: reduced breathing effort, especially with concomitant CNS depressants.
• Seizures: rare occurrence of convulsive episodes.
• Severe hypotension: marked drop in blood pressure.
• Allergic reactions: rash, itching, or anaphylaxis in susceptible individuals.

When prescribing sodium oxybate, clinicians should consider several safety measures.

• Dose titration: start with a low dose and increase only under medical supervision.
• Alcohol avoidance: do not consume alcohol while taking the medication.
• Renal impairment: assess kidney function and adjust therapy as needed.
• Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Sodium oxybate can interact with other central nervous system depressants and certain medications.

Major Interactions (Avoid)

• Alcohol: additive CNS depression leading to severe respiratory effects.
• Opioids: increased risk of respiratory depression and sedation.
• Benzodiazepines: enhanced sedative effects and possible profound CNS depression.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs, SNRIs): may influence cataplexy frequency.
• Antihypertensives: potential additive hypotensive effect requiring blood pressure monitoring.